Roche is dedicated to helping save patients’ lives by delivering state-of-the-art donor screening solutions that help protect the global blood supply from infectious diseases. High-sensitivity blood screening technologies support the transfusion of safe blood by providing blood banks with high-quality laboratory tests.
Roche provides two blood screening technologies:
Ensuring access to a sufficient and safe supply of whole blood and plasma products is a challenge.1 As a global leader and provider of the most comprehensive donor screening solution to blood centres and plasma fractionators worldwide, Roche recognizes this challenge and is committed to keeping the blood and plasma supply safe. To this end, we:
As the only single provider for nucleic acid testing (NAT), serology, lab automation and software solutions to blood centres and plasma fractionators worldwide, Roche offers the most comprehensive solution for whole blood and plasma screening. Experience the simplicity of leveraging a one-provider solution that increases workflow efficiencies and reduces the risk of manual handling errors.
Roche, an industry leader in Nucleic Acid Testing (NAT) blood screening, uses PCR technology for early detection of infectious agents to help reduce disease transmission risk to blood transfusion patients.
Our customers choose Roche to minimize complexity and manual processes, reduce time to release safe blood products, test efficiently at large volumes, and scale to handle future requirements. We help deliver these advantages with:
You have a vision for your lab. We are here to help you build it at your pace and preference with:
References:
